---
title: "Orally bioavailable and blood–brain barrier-penetrating ATM inhibitor (AZ32) radiosensitizes intracranial gliomas in mice"
collection: publications
permalink: /publication/2018-AZ32-MolCancerTher
excerpt: 'Development of orally bioavailable ATM inhibitor for glioma treatment.'
date: 2018-08-01
venue: 'Molecular Cancer Therapeutics'
paperurl: 'https://doi.org/10.1158/1535-7163.MCT-17-1212'
citation: 'Karlin J, Allen J, Ahmad SF, Hughes G, Sheridan V, Odedra R, Farrington P, Cadogan E, Riches L, Sharma S, Smith A, Reddy P, Lau A, O'Connor M, Loh V, Yap T, Plummer R, Forster M, Sule A, Durant S, Golding S, McMahon M, Valerie K. (2018). &quot;Orally bioavailable and blood–brain barrier-penetrating ATM inhibitor (AZ32) radiosensitizes intracranial gliomas in mice.&quot; <i>Molecular Cancer Therapeutics</i>. 17(8):1637-1647.'
---
